...
首页> 外文期刊>Oncology reports >Increase in E-selectin expression in umbilical vein endothelial cells by anticancer drugs and inhibition by cimetidine.
【24h】

Increase in E-selectin expression in umbilical vein endothelial cells by anticancer drugs and inhibition by cimetidine.

机译:抗癌药增加脐静脉内皮细胞中E-选择素的表达,西咪替丁抑制作用。

获取原文
获取原文并翻译 | 示例
           

摘要

E-selectin is expressed on the surfaces of stimulated vascular endothelial cells and is sometimes involved in cancer cell metastasis. The H2-receptor antagonist cimetidine inhibits the increase in E-selectin expression on vascular endothelial cells that is induced by interleukin-1beta (IL-1beta) and cimetidine. It also inhibits the adhesion of sialyl-Lewis-antigen-positive cancer cells to vascular endothelial cells, ultimately inhibiting hematogenous metastasis. Anticancer drugs are essential to cancer therapy, but whether they can alter the expression of E-selectin in vascular endothelial cells remains unclear. Whether cimetidine inhibits the expression of E-selectin in the same manner in the presence or absence of anticancer drugs also remains unknown. Human umbilical vein endothelial cells were cultured with 5-fluorouracil (5-FU), doxorubicin (DXR), cisplatin (CDDP), or IL-1beta and with or without cimetidine. The expression of E-selectin at the mRNA and protein levels was then determined using quantitative reverse transcription-polymerase chain reaction and immunohistochemical staining, respectively. The E-selectin mRNA level increased in cells exposed to 5-FU, DXR, or CDDP, but the addition of cimetidine had no effect on the E-selectin mRNA level. The expression of E-selectin protein was also significantly higher after the addition of 5-FU, DXR, or CDDP, compared with that of a negative control. However, when cimetidine was added prior to the addition of 5-FU, DXR, or CDDP, the expression of E-selectin was significantly suppressed. Thus, cimetidine significantly inhibited the expression of E-selectin at the protein level without affecting its expression at the mRNA level in cells treated with anticancer drugs. In conclusion, anticancer drugs increased the expression of E-selectin and this increase was inhibited by cimetidine. These findings suggest that the administration of cimetidine during treatment with anticancer drugs might be useful for preventing metastasis.
机译:E-选择蛋白在受刺激的血管内皮细胞表面表达,有时与癌细胞转移有关。 H2受体拮抗剂西咪替丁可抑制白介素-1β(IL-1beta)和西咪替丁诱导的血管内皮细胞E选择素表达的增加。它也抑制了唾液酸化-刘易斯抗原阳性的癌细胞对血管内皮细胞的粘附,最终抑制了血源性转移。抗癌药物对于癌症治疗至关重要,但是尚不清楚它们是否能够改变血管内皮细胞中E-选择素的表达。在存在或不存在抗癌药的情况下,西咪替丁是否以相同的方式抑制E-选择素的表达仍是未知的。将人脐静脉内皮细胞与5-氟尿嘧啶(5-FU),阿霉素(DXR),顺铂(CDDP)或IL-1beta以及有或没有西咪替丁一起培养。然后分别使用定量逆转录-聚合酶链反应和免疫组化染色确定E-选择素在mRNA和蛋白水平上的表达。在暴露于5-FU,DXR或CDDP的细胞中,E-选择素mRNA水平升高,但是添加西咪替丁对E-选择素mRNA水平没有影响。与阴性对照相比,添加5-FU,DXR或CDDP后E-选择素蛋白的表达也明显更高。但是,当在添加5-FU,DXR或CDDP之前添加西咪替丁时,E-选择蛋白的表达被显着抑制。因此,在用抗癌药处理的细胞中,西咪替丁在蛋白质水平上显着抑制E-选择蛋白的表达,而在mRNA水平上不影响其表达。总之,抗癌药增加了E-选择素的表达,而这种增加被西咪替丁抑制了。这些发现表明在用抗癌药治疗期间给予西咪替丁可能对预防转移有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号